Incidence, Predictors and In-hospital Outcomes of No Reflow Phenomenon During Percutaneous Coronary Intervention for Acute Myocardial Infarction

被引：0
|
作者：
Aggarwal, Atul [1 ]
Ou, Fang-shu [2 ]
Klein, Lloyd W. [3 ]
Rumsfeld, John S. [4 ]
Roe, Matthew T. [2 ]
Wang, Tracy Y. [2 ]
机构：
[1] Comprehens Cardiovasc Med Grp, Bakersfield, CA USA
[2] Duke Clin Rsch Inst, Durham, NC USA
[3] Rush Med Sch, Chicago, IL USA
[4] VA Med Cntr, Denver, CO USA
来源：
CIRCULATION | 2009年 / 120卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S986 / S986
页数：1
相关论文
共 50 条
  • [41] Administration of adenosine triphosphate disodium during primary percutaneous coronary intervention in acute myocardial infarction reduces no-reflow and lessens in-hospital cardiac adverse events
    Sakuma, T.
    Okada, T.
    Otsuka, M.
    Toyofuku, M.
    Hirao, H.
    Muraoka, Y.
    Ueda, H.
    Masaoka, Y.
    Hayashi, Y.
    EUROPEAN HEART JOURNAL, 2007, 28 : 621 - 622
  • [42] Predictors and Long-term Prognosis of Angiographic Slow/No-Reflow Phenomenon During Emergency Percutaneous Coronary Intervention for ST-Elevated Acute Myocardial Infarction
    Li Dong-bao
    Hua Qi
    Liu Zhi
    Wang Shan
    Jin Wei-ying
    CLINICAL CARDIOLOGY, 2010, 33 (12) : E7 - E12
  • [43] Impact of Vascular Disease on In-Hospital Mortality Following Percutaneous Coronary Intervention for Acute Myocardial Infarction
    Patel, Jignesh
    Brown, David L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A58 - A59
  • [44] In-hospital clinical outcomes of the oldest-old patients with acute myocardial infarction treated with primary percutaneous coronary intervention
    Yamaguchi, T.
    Miyamoto, T.
    Kawahatsu, K.
    Miyazaki, R.
    Hara, N.
    Yagishita, A.
    Umemoto, T.
    Yamauchi, Y.
    Obayashi, T.
    Isobe, M.
    EUROPEAN HEART JOURNAL, 2014, 35 : 478 - 478
  • [45] Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction
    Naing, Kyaw Aung
    Li, Lang
    Su, Qiang
    Wu, Taixiang
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (06):
  • [46] Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction
    Su, Qiang
    Nyi, Tun Swe
    Li, Lang
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (05):
  • [47] Risk Factors of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction Female Patients
    Lu, D. B.
    Chen, Z. W.
    Yu, Z. Q.
    Xia, Y.
    Chen, A.
    Shu, X. H.
    Qian, J. Y.
    Ge, J. B.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 : S486 - S486
  • [48] Predictors of No-Reflow Phenomenon in Tunisian Patients Undergoing Primary Percutaneous Coronary Intervention for St-Elevation Myocardial Infarction
    Jomaa, Walid
    Jnifene, Zouhair
    Chamtouri, Ikram
    Ben Hamda, Khaldoun
    Maatouk, Faouzi
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (04) : S9 - S9
  • [49] Predictors of in-hospital mortality in patients with acute myocardial infarction complicated by cardiogenic shock in the contemporary era of primary percutaneous coronary intervention
    Ong, H. A.
    Ho, H. H.
    Arasaratnam, P.
    Ali, A.
    Ooi, Y. W.
    Tan, K. B. J.
    Loh, K. K.
    Jafary, F. H.
    Foo, D.
    Ong, P. J. L.
    EUROPEAN HEART JOURNAL, 2012, 33 : 464 - 464
  • [50] In-Hospital Outcomes Following Coronary Atherectomy During Percutaneous Coronary Intervention
    Skinner, Kristina
    Paul, Timir
    Kumar, Sachin
    Hashemzadeh, Mehrtash
    Movahed, Mohamed
    Shanmugasundaram, Madhan
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (04) : S16 - S17
12345